(Q50872728)
Statements
Efficacy of continuous subcutaneous insulin infusion (CSII) in patients with classical contraindications to its use. (English)
1 reference
C Frampton
1 reference
J Berkeley
1 reference
H Lunt
1 reference
1 November 2007
1 reference
24
1 reference
12
1 reference
1496-1497
1 reference
1 reference
1 reference